Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 44, 2014 - Issue 10
316
Views
12
CrossRef citations to date
0
Altmetric
Pharmacogenetics

Clinical symptoms in fibromyalgia are associated to catechol-O-methyltransferase (COMT) gene Val158Met polymorphism

, , , , , & show all
Pages 952-956 | Received 10 Feb 2014, Accepted 04 Apr 2014, Published online: 24 Apr 2014

References

  • Ablin JN, Cohen H, Buskila D. (2006). Mechanisms of disease: genetics of fibromyalgia. Nat Clin Pract Rheumatol 2:671–8
  • Barbosa FR, Matsuda JB, Mazucato M, et al. (2012). Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients. Rheumatol Int 32:427–30
  • Beck AT, Epstein N, Brown G, Steer RA. (1988). An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893–7
  • Beck AT, Ward CH, Mendelson M, et al. (1961). An inventory for measuring depression. Arch Gen Psychiatry 4:561–71
  • Buskila D, Sarzi-Puttini P. (2006). Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome. Arthritis Res Ther 8:218--22
  • Desmeules J, Piguet V, Besson M, et al. (2012). Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphism. Health Psychol 31:242–9
  • Diatchenko L, Nackley A, Slade G, et al. (2006). Idiopathic pain disorders: pathways of vulnerability. Pain 123:226–30
  • Fernández-de-Las-Peñas C, Ambite-Quesada S, Gil-Crujera A, et al. (2012). Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome. J Pain 13:1068–74
  • Finan PH, Zautra AJ, Davis MC, et al. (2011). COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia. Pain 152:300–7
  • Freedman RR, Ianni P. (1983). Role of cold and emotional stress in Raynaud's disease and scleroderma. Br Med J 287:1499–502
  • Galvão AC, Krüger RC, Campagnolo PD, et al. (2012). Association of MAOA and COMT gene polymorphisms with palatable food intake in children. J Nutr Biochem 23:272–7
  • Greenwood PM, Parasuraman R. (2003). Normal genetic variation, cognition, and aging. Behav Cogn Neurosci Rev 2:278–306
  • Gürsoy S, Erdal E, Herken H, et al. (2003). Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 23:104–7
  • Josep García-Fructuoso FJ, Lao-Villadóniga JI, Beyer K, et al. (2006). Relationship between catechol-O-methyltransferase genotypes and fibromyalgia's severity. Rheumatol Clin 2:168–72
  • Kato K, Sullivan PF, Evengard B, et al. (2006). Importance of genetic influences on chronic widespread pain. Arthritis Rheum 54:1682–6
  • Khasar SG, Green PG, Miao FJ, et al. (2003). Vagal modulation of nociception is mediated by adrenomedullary epinephrine in the rat. Eur J Neurosci 17:909–15
  • Lachman HM, Papolos DF, Saito T, et al. (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243–50
  • Lavigne JA, Helzlsouer KJ, Huang HY, et al. (1997). An association between the allele coding for a low activity variant of catechol-O-methyltransferase and risk of breast cancer. Cancer Res 57:5493–7
  • Lee YH, Choi SJ, Ji JD, et al. (2012). Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol Int 32:417–26
  • Mannisto P, Kaakkola S. (1999). Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593–628
  • Marasini B, Biondi ML, Mollica R, et al. (1991). Cold-induced changes in plasma norepinephrine, epinephrine and dopamine concentrations in patients with Raynaud's phenomenon. Eur J Clin Chem Clin Biochem 29:111–14
  • Markkula R, Jarvinen P, Leino-Arjas P, et al. (2009). Clustering of symptoms associated with fibromyalgia in a Finnish twin cohort. Eur J Pain 13:744–50
  • Martínez-Jauand M, Sitges C, Rodríguez V, et al. (2013). Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene. Eur J Pain 17:16–27
  • Nackley AG, Tan KT, Fecho K, et al. (2007). Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both b2- and b3-adrenergic receptors. Pain 128:199–208
  • Neumann L, Buskila D. (2003). Epidemiology of fibromyalgia. Curr Pain Headache Rep 7:362–8
  • Salli A, Yilmaz H, Ugurlu H. (2012). The relationship between tender point count and disease severity in patients with primary fibromyalgia. Rheumatol Int 32:105–7
  • Sarmer S, Ergin S, Yavuzer G. (2000). The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12
  • Secher A, Bukh J, Bock C, et al. (2009). Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1. Int Clin Psychopharmacol 24:199–203
  • Tammimäki A, Männistö PT. (2012). Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis. Pharmacogenet Genom 22:673–91
  • Tander B, Gunes S, Boke O, et al. (2008). Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility. Rheumatol Int 28:685–91
  • Topbas M, Cakırbay H, Gulec H, et al. (2005). The prevalence of fibromyalgia in women aged 20–64 in Turkey. Scand J Rheumatol 34:140–4
  • Wolfe F, Ross K, Anderson J, et al. (1995). The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28
  • Wolfe F, Smythe HA, Yunus MB, et al. (1990). The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–72
  • Zhu BT, Conney AH. (1998). Functional role of estrogen metabolism in target cells:review and perspectives. Carcinogenesis 19:1–27
  • Zubieta JK, Heitzeg MM, Smith YR, et al. (2003). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240–3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.